Open Accessibility Menu

Monthly investment news and growth insights — straight to your inbox. Sign up to our newsletter.

Current

TidalSense External Link

Technology
London
Early Stage
2020

The medtech company TidalSense, formerly Cambridge Respiratory Innovations (CRI), creates ground-breaking respiratory technologies for quicker, more accurate, and automated diagnostics.

TidalSense first received funding from BGF and Downing Ventures in December 2020, to fast-track research and development of its award-winning N-Tidal device.

The N-Tidal device is a first-in-kind, connected, handheld capnometer incorporating unique patented sensor technology, that can accurately measure carbon dioxide levels in exhaled breath during normal breathing. It helps medical professionals diagnose and monitor respiratory conditions.